FINRA SIPC
  
Ticker Symbol Company Name

This Week's Research

Date Type Headline  
07/29/2010 Update WIBC ($8.00, Neutral): Loan sales and charge-offs prepare Wilshire for profitable 2H10. Reaffirm "Neutral" rating.  View Document  
07/29/2010 Update CLFC ($5.18*, Buy): Beats 2Q10 Estimates With Lower Provision, Bargain Purchase Gain. Reiterating "Buy" Rating  View Document  
07/29/2010 Update SUSQ ($8.73*, N/A): Review of 2Q10 Results  View Document  
07/29/2010 Morning Note B. Riley & Co. Morning Notes: ACTU, CATY, DRCO, EGHT, ELNK, EWBC, EXAR, LOOP, NARA, NEWP, OPLK, PPC, SIMO, TRMK, UNCA, WIBC  View Document  
07/29/2010 Update TRMK ($22.33, Neutral): Several positive developments in Q2; reaffirming "Neutral" rating  View Document  
07/29/2010 Update EGHT ($1.49, Buy): Raising estimates as EGHT kick starts FY '11 with an across-the-board beat in Q1 (Jun)  View Document  
07/29/2010 Update NEWP ($10.83, Buy): Strong Q2 Results; Raising PT and Maintain "Buy"   View Document  
07/29/2010 Update CATY ($11.67, Neutral): Reports Better-Than-Expected 2Q10 Results. Reaffirm "Neutral" Rating.  View Document  
07/29/2010 Initiation of Coverage SIX ($32.54, Buy): B. Riley & Co. Initiation of Coverage: Initiating Coverage on Six Flags Entertainment Corporation with a "Buy" Rating and $45.00 Price Target  View Document  
07/28/2010 Update ELNK ($8.92, Buy): The tree fell in the forest, but not many heard; It may take New Edge monetization to get fair value for a still-outperforming ELNK  View Document  
07/28/2010 Update SBNY ($38.70, Buy): Reports Robust Results Despite Temporary NIM Compression; Reaffirming "Buy" Rating  View Document  
07/28/2010 Update EWBC ($15.88*, Buy): 2Q10 Results Demonstrate Positive Earnings Momentum. Reiterating "Buy" Rating  View Document  
07/28/2010 Update UMPQ ($12.75, Buy): 2Q10 Results Show Continued Improvements in Asset Quality. Reiterating "Buy" Rating.  View Document  
07/28/2010 Update TRMK ($22.30*, Neutral): Several Positive Developments in Q2 - Reaffirming "Neutral" Rating  View Document  
07/28/2010 Update KEYN ($9.49, Buy): Reports Q3 '10 Results; Reiterate "Buy" Rating  View Document  
07/28/2010 Update SNAK ($3.30; Buy): Reports Q2 Results; Jamba National with WMT, SWY, TGT  View Document  
07/28/2010 Morning Note B. Riley & Co. Morning Notes: AXTI, COHR, DRCO, EGHT, ELNK, FBP, FNB, SNAK, KEYN, LOOP, OCLR, PVSW, SBNY, SHOO, UMPQ, VLCM, WTSLA, WSFS  View Document  
07/28/2010 Update WSFS ($38.24, Buy): Reports Improved Results & Asset Quality Stabilization - Reaffirming "Buy" Rating  View Document  
07/28/2010 Update NARA ($7.40, Buy): Aggressive Problem Loan Actions Result in Large 2Q10 Loss, but Better Positions Company for Future. Reiterating "Buy" Rating  View Document  
07/28/2010 Update LOOP ($12.39; Neutral): Reports Q2 Results; Update on Industry Conditions  View Document  
07/28/2010 Update PVSW ($4.81, Buy): Reports Q4 '10 Results; Reiterate "Buy" Rating  View Document  
07/28/2010 Update FBP ($0.61, Buy): Posts Larger-Than-Expected Loss, but Positive Asset Quality Trends. Reiterating "Buy" Rating.  View Document  
07/27/2010 Update RNST ($15.39, Buy): RNST announces FDIC acquisition & capital raise; reaffirming "Buy" rating  View Document  
07/27/2010 Update PCTI ($6.03, Buy): PCTI beats, raises; increasing price target to $6.93  View Document  
07/27/2010 Update BOH ($50.29, Neutral): Announces Strong 2Q10 Results and Resumption of Share Buyback Program. Reaffirming "Neutral" Rating.   View Document  
07/27/2010 Morning Note B. Riley & Co. Morning Notes: BOH, CALD, CATY, CLFC, CPF, CVBF, EPIC, EWBC, FBP, FNB, MSPD, NARA, NEWP, PCTI, PFBC, RNST, STMP  View Document  
07/27/2010 Update FNB ($8.64*, Buy): FNB Reports Improved Q2 Results – Upgrading to "Buy" on Highly Attractive Dividend Yield & Lower Perceived Risks  View Document  
07/27/2010 Update MSPD ($8.80, Neutral): Announced June quarter results and provided September quarter guidance  View Document  
07/26/2010 Update BPOP($2.62, Buy): Raising EPS Estimates and Target Price Following Encouraging Asset Quality Trends. Reiterating "Buy" Rating  View Document  
07/26/2010 Update PRSP($33.68, Buy): Reports Another Solid Quarter - Reaffirming "Buy" Rating  View Document  
07/26/2010 Update WL($9.88, Neutral): Reports Huge Loss on Mounting Credit Woes; Downgrading to "Neutral"  View Document  
07/26/2010 Update TBBK ($7.63*, Buy): Reducing Estimates & Maintaining "Buy" Rating on Steeply Discounted Valuation  View Document  
07/26/2010 Morning Note B. Riley & Co. Morning Notes: BPOP, ELNK, GBCI, HOMB, IBKC, KEYN, PVSW, PRSP, Q2 '10 Earnings Preview Update, RNST, SABA, SBNY, TCBI, TRMK, WL  View Document  
07/26/2010 Update Q2 '10 Earnings Preview - Sorted by Name  View Document  
07/26/2010 Update Q2 '10 Earnings Preview - Sorted by Date  View Document  
07/26/2010 Update IBKC($50.21, Buy): Review of Q2 Results & FDIC Acquisition - Reaffirming "Buy" Rating  View Document  
07/23/2010 Update CYN ($53.00, Neutral): CYN – Asset quality continues to improve, leading to strong 2Q10 performance. Reiterating "Neutral" rating.   View Document  
07/23/2010 Update ITI ($1.46, N/A): Q1 earnings beat; Strong sensors business; Systems remains soft due to budgetary constraints; P&L turnaround has begun.  View Document  
07/23/2010 Update CSGP ($42.42; Buy): CSGP Beats and Raises Guidance; Reiterate “Buy” Rating  View Document  
07/23/2010 Update HBHC ($28.79, Buy): Reports Miss on Disappointing Asset Quality - Reaffirming "Buy" Rating on Valuation  View Document  
07/23/2010 Update GBCI ($16.19*, Buy): 2Q10 Results Show Asset Quality Improvements. Reaffirming "Buy" Rating  View Document  
07/23/2010 Update HOMB ($22.63*, Neutral): HOMB Announces Strong 2Q10 Results - Maintain "Neutral" Rating  View Document  
07/23/2010 Update TCBI ($15.21*, Buy): NPAs/Assets Increased, But There Are Signs of Stabilization - Reaffirming "Buy" Rating  View Document  
07/23/2010 Morning Note B. Riley & Co. Morning Notes: AFOP, AXTI, CSGP, CYN, DRCO, FNB, GBCI, HBHC, ITI, KEYN, KTOS, OPNT, Optical Component Industry, PCTI, STEC, WSFS  View Document  
07/23/2010 Update AFOP ($1.55, Buy): Strong Q2 results; Reiterate Buy  View Document